Global Market Presence Cenduit has a global presence with operations in the US, UK, Switzerland, India, Japan, and China, interacting with over 600,000 patients at more than 32,000 sites. This extensive reach presents opportunities for expanding sales internationally.

Innovative Technology Solutions Cenduit uses cutting-edge technology stack including React, D3.js, and NoSQL. Leveraging these advanced technologies in developing IRT platforms and patient engagement solutions can be a strong selling point to tech-savvy clients seeking innovative solutions.

Strategic Funding Position With a revenue in the range of $100M - 1B, Cenduit demonstrates financial stability, which can instill confidence in potential clients looking for long-term partnerships. Highlighting this financial strength can help in securing contracts with major pharmaceutical companies or CROs.

Industry Recognition & Partnerships Cenduit's CEO and senior directors have been recognized by industry awards such as the Grant Thornton North Carolina 100® list. These accolades and partnerships with leading companies like Quintiles and Thermo Fisher enhance Cenduit's credibility in the market, presenting opportunities to attract clients through association with reputable organizations.

Diversified Product Portfolio Cenduit offers a wide range of IRT-driven services including patient randomization, clinical supply chain management, patient engagement, and materials forecasting. Highlighting the versatility and comprehensiveness of their services can help in catering to the diverse needs of clients in the clinical trial industry, potentially opening doors to cross-selling opportunities.